5428-35-3 Usage
Chemical class
Imidazolidines A class of organic compounds derived from imidazole, a five-membered ring containing two nitrogen atoms.
Potential biological activities
Antihypertensive and antiviral agent Studies have shown that 1,3-bis(4-chlorobenzyl)-2-(4-methoxyphenyl)imidazolidine may have potential in treating high blood pressure and viral infections.
Pharmacological properties
Promising candidate for further research The compound's structural features and potential biological activities make it an interesting target for additional research into its therapeutic applications.
Therapeutic applications
Possible use in treating hypertension and viral infections Based on its potential biological activities, 1,3-bis(4-chlorobenzyl)-2-(4-methoxyphenyl)imidazolidine could be developed into a drug for treating these conditions.
Derivative of imidazole
Structural similarity to the parent compound As a derivative of imidazole, 1,3-bis(4-chlorobenzyl)-2-(4-methoxyphenyl)imidazolidine shares some structural similarities with the parent compound, which may contribute to its pharmacological properties.
Research focus
Further investigation into its pharmacological properties and potential therapeutic applications Given its potential biological activities and structural features, more research is needed to fully understand the compound's properties and its potential as a therapeutic agent.
Check Digit Verification of cas no
The CAS Registry Mumber 5428-35-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,4,2 and 8 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 5428-35:
(6*5)+(5*4)+(4*2)+(3*8)+(2*3)+(1*5)=93
93 % 10 = 3
So 5428-35-3 is a valid CAS Registry Number.
5428-35-3Relevant academic research and scientific papers
Caterina, Maria C.,Figueroa, Maria A.,Perillo, Isabel A.,Salerno, Alejandra
, p. 701 - 712 (2006)
A study about the scope of the method for the attainment of 4,5-dihydro-1H-imidazolium salts by dehydrogenation of N,N′-dibenzyl- and N-aryl-N′-benzylimidazolidines is presented. Employed dehydrogenating agents were N-bromoacetamide (NBA), N-bromosuccinim
